Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Deloitte
Colorcon
Covington
Merck
Chinese Patent Office

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 7,662,143

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,662,143
Title:Apparatus and method for treating intravascular disease
Abstract: Medical devices and methods of treatment using medical devices, and more particularly, methods of treating a treatment site in a blood vessel and devices or apparatuses for use therewith. In some embodiments, a method and apparatus for treating a treatment site in a blood vessel using fluid movement or agitation adjacent the treatment site is disclosed. In some embodiments, an apparatus is provided including one or more deployable structures adapted to create fluid movement within the vessel. The apparatus is inserted into the vessel, and the deployable structure is positioned adjacent the treatment site. The deployable structure is used to create fluid movement adjacent to the treatment site. In some embodiments, a treatment material, such as a medicine or drug, is introduced into the vessel proximate the treatment site, and the deployable structure is used to create fluid movement or agitation adjacent the treatment site to create a better interface between the treatment site and the medicine, or to move the medicine into the treatment site. In some embodiments, the fluid movement created by the deployable member aids in removal of tissue or other material from the treatment site.
Inventor(s): Carrison; Harold (Pleasanton, CA), Abrams; Robert M. (Los Gatos, CA), Casados; Jesse E. (San Ramon, CA), Farnholtz; Roger (Fremont, CA)
Assignee: Boston Scientific Scimed, Inc. (Maple Grove, MN)
Application Number:10/629,114
Patent Claims:see list of patent claims

Details for Patent 7,662,143

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Ekr Therap RETAVASE reteplase VIAL 103786 001 1998-05-06 ➤ Sign Up Boston Scientific Scimed, Inc. (Maple Grove, MN) 2036-04-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fuji
Citi
Express Scripts
McKesson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.